Skip to main content
Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
1.650
+0.050 (3.13%)
At close: Dec 20, 2024, 4:00 PM
1.660
+0.010 (0.61%)
After-hours: Dec 20, 2024, 6:26 PM EST

Longeveron Revenue

Longeveron had revenue of $773.00K in the quarter ending September 30, 2024, with 415.33% growth. This brings the company's revenue in the last twelve months to $1.85M, up 141.46% year-over-year. In the year 2023, Longeveron had annual revenue of $709.00K, down -41.98%.

Revenue (ttm)
$1.85M
Revenue Growth
+141.46%
P/S Ratio
5.59
Revenue / Employee
$77,167
Employees
24
Market Cap
24.48M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023709.00K-513.00K-41.98%
Dec 31, 20221.22M-84.00K-6.43%
Dec 31, 20211.31M-4.32M-76.80%
Dec 31, 20205.63M-10.47K-0.19%
Dec 31, 20195.64M3.50M164.17%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Vivos Therapeutics 14.58M
Cara Therapeutics 8.69M
Lipocine 7.92M
Co-Diagnostics 7.32M
NeuroOne Medical Technologies 3.45M
Alterity Therapeutics 2.68M
Pluri 598.00K
Revenue Rankings

LGVN News

More News